Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.

BACKGROUND Chitinase 3-like 1 (CHI3L1), neurofilament light chain (NFL) and oligoclonal bands (OCB) in cerebrospinal fluid are associated with central nervous system demyelination in adults. CHI3L1 and OCB are markers of central nervous system inflammation, whereas NFL is a marker of white-matter axonal injury. The aim was to examine whether CHI3L1 and NFL in cerebrospinal fluid are associated with acquired demyelinating syndromes at disease onset in a pediatric population. METHODS Children (<18 years) referred to hospital for possible neuroinflammatory disease were retrospectively included from 2010 to 2016. Case ascertainment was by review of medical records. NFL and CHI3L1 were measured by enzyme-linked immunosorbent assays. Endpoints were differences in concentrations of cerebrospinal fluid NFL and CHI3L1. RESULTS We included 193 children who all underwent cerebrospinal fluid OCB examination as part of their diagnostic work-up and classified these children into 5 groups: acquired demyelinating syndromes (n = 33), normal diagnostic work-up (n = 36), inflammatory neurological disease (n = 50), other neurological disease (n = 55), and systemic inflammatory diseases (n = 19). NFL and CHI3L1 in cerebrospinal fluid differed significantly between the five groups (p = 0.0001). CHI3L1 was significantly higher in acquired demyelinating syndromes than in all other groups, and NFL was significantly higher in acquired demyelinating syndromes than in the other groups except systemic inflammatory disease. Children with acute disseminated encephalomyelitis had significantly higher concentrations of CHI3L1 than did children with multiple sclerosis. CONCLUSION We provide class II evidence that CHI3L1 and NFL are associated with pediatric acquired demyelinating syndromes. CHI3L1 may help distinguishing between acute disseminated encephalomyelitis and multiple sclerosis, but this needs further confirmation.

[1]  Henrik Zetterberg,et al.  Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa , 2016, Clinical chemistry and laboratory medicine.

[2]  K. Blennow,et al.  Cerebrospinal fluid brain injury biomarkers in children: a multicenter study. , 2013, Pediatric neurology.

[3]  N. Chamoles,et al.  Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients , 2002, Neurology.

[4]  D. Li,et al.  Role of MRI in the differentiation of ADEM from MS in children , 2009, Neurology.

[5]  S. Suissa,et al.  Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[6]  C. McCulloch,et al.  Younger children with MS have a distinct CSF inflammatory profile at disease onset , 2010, Neurology.

[7]  P. Vermersch,et al.  Natural history of multiple sclerosis with childhood onset. , 2007, The New England journal of medicine.

[8]  S. Verhulst,et al.  CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders , 2014, Journal of Neuroimmunology.

[9]  B. Healy,et al.  Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. , 2009, Archives of neurology.

[10]  À. Rovira,et al.  Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. , 2015, Brain : a journal of neurology.

[11]  T. Olsson,et al.  Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers , 2013, PloS one.

[12]  Daniela Pohl,et al.  Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study , 2011, The Lancet Neurology.

[13]  R. Dale,et al.  Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions , 2007, Developmental medicine and child neurology.

[14]  A. Starkey,et al.  In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases , 2010, Journal of Neuroinflammation.

[15]  F. Hanefeld,et al.  CSF characteristics in early-onset multiple sclerosis , 2004, Neurology.

[16]  D. De Grandis,et al.  Acute disseminated encephalomyelitis in children: focus on relapsing patients. , 2008, Pediatric neurology.

[17]  S. Lehmann,et al.  Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis , 2015, Multiple sclerosis.

[18]  M. Calabrese,et al.  Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study , 2009, Multiple sclerosis.

[19]  J. Lundgren,et al.  YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis , 2002, Clinical and Vaccine Immunology.

[20]  D. Arnold,et al.  2010 McDonald criteria for diagnosing pediatric multiple sclerosis , 2012, Annals of neurology.

[21]  À. Rovira,et al.  Neurofilament light chain level is a weak risk factor for the development of MS , 2016, Neurology.

[22]  M Ramanathan,et al.  Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. , 2009, Brain : a journal of neurology.

[23]  A. Ghezzi,et al.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.

[24]  K. Wenner,et al.  Oligoclonal bands predict multiple sclerosis in children with optic neuritis , 2015, Annals of neurology.

[25]  M. Blinkenberg,et al.  Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study , 2018, Developmental medicine and child neurology.

[26]  H. Stroink,et al.  Prognostic factors after a first attack of inflammatory CNS demyelination in children , 2008, Neurology.

[27]  J. Frederiksen,et al.  Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis , 2015, Multiple sclerosis.

[28]  Li Wang,et al.  Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long‐term follow‐up: comparison of presenting features , 2009, Developmental medicine and child neurology.

[29]  M. Blinkenberg,et al.  Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977–2015: A nationwide population-based incidence study , 2018, Multiple sclerosis.

[30]  T. Friede,et al.  Clinical presentation of pediatric multiple sclerosis before puberty , 2014, European journal of neurology.

[31]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[32]  À. Rovira,et al.  Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. , 2010, Brain : a journal of neurology.

[33]  L. Rosengren,et al.  Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children , 2008, Pediatric blood & cancer.

[34]  F. Drago,et al.  Evaluation of CHI3L-1 and CHIT-1 Expression in Differentiated and Polarized Macrophages , 2012, Inflammation.

[35]  N. Gilhus,et al.  Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force , 2006, European journal of neurology.

[36]  B. Ma,et al.  Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. , 2011, Annual review of physiology.